| Current status and contemporary approaches to the discovery of antitumor agents from higher plants G Agarwal, PJB Carcache, EM Addo, AD Kinghorn Biotechnology advances 38, 107337, 2020 | 97 | 2020 |
| Targeting protein translation by rocaglamide and didesmethylrocaglamide to treat MPNST and other sarcomas LS Chang, JL Oblinger, SS Burns, J Huang, LW Anderson, ... Molecular cancer therapeutics 19 (3), 731-741, 2020 | 17 | 2020 |
| Structurally Modified Cyclopenta[b]benzofuran Analogues Isolated from Aglaia perviridis G Agarwal, JR Wilson, SJ Kurina, GD Anaya-Eugenio, TN Ninh, ... Journal of natural products 82 (10), 2870-2877, 2019 | 14 | 2019 |
| Update on phytochemical and biological studies on rocaglate derivatives from Aglaia species G Agarwal, LS Chang, DD Soejarto, AD Kinghorn Planta medica 87 (12/13), 937-948, 2021 | 9 | 2021 |
| Comparative study of cytokinin production isolated from bacteria and shoot induction S Sabat, VK Murthy, SL Shantha, D Kushnoor, G Agarwal, J Thomas, ... NISCAIR-CSIR, India, 2014 | 8 | 2014 |
| The eIF4A inhibitors didesmethylrocaglamide and rocaglamide as effective treatments for pediatric bone and soft-tissue sarcomas LS Chang, JL Oblinger, G Agarwal, TA Wilson, R Roberts, J Fuchs, ... Cancer Research 80 (16_Supplement), 1950-1950, 2020 | 1 | 2020 |
| Phytochemical Study of Flavaglines from Aglaia perviridis and Their Rapid Dereplication in Selected Tropical Plant Samples G Agarwal The Ohio State University, 2019 | 1 | 2019 |
| Bioactivity-guided isolation and quantification of episilvestrol and silvestrol from Aglaia perviridis G Agarwal, L Pan, CB Naman, HB Chai, TN Ninh, DD Soejarto, ... Planta Medica 81 (11), PX35, 2015 | | 2015 |
